CDEK
← All drugs Report issue

barbexaclonum

Small moleculeexperimental

Phenobarbital is a barbiturate derivative used to treat insomnia and anxiety, seizures, hyperbilirubinemia in neonates and cholestasis. Phenobarbital promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride currents through receptor channels. — NCATS

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Indications

Approved for

Mechanism of action

  • Unspecified targetOTHER

    Unknown

    Barbexaclone is a potent antiepileptic. It is a salt compound of phenobarbital and propylhexedrine. While barbexaclone has sedative properties, propylhexedrine has psychostimulant properties intended to offset these sedative effects.

Chemistry & pharmacology

Loading structure…

SMILES

CN[C@@H](C)CC1CCCCC1.CCC2(C(=O)NC(=O)NC2=O)C3=CC=CC=C3
Mol. weight
387.5157 g/mol
Chirality
Racemic Mixture
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • barbexaclon
  • barbexaclon
  • barbexaclon
  • barbexaclona
  • barbexaclona
  • barbexaclone
  • barbexaclone
  • barbexaclone
  • barbexaclone
  • barbexaclone
  • barbexaclone
  • barbexaclonum
  • barbexaclonum
  • barbexaclonum
  • bc brand of barbexaclone
  • chp phenobarbital
  • maliasin
  • maliasin
  • maliasin
  • phenobarbital propylhexedrine salt